However, when combined with insulin or sulfonylureas, the risk increases, and dose adjustments of these concurrent medications may be necessary
Comparing GLP-1 Options The Role of Telehealth in Accessing Treatment The rise of telehealth has fundamentally changed how people access weight loss support
Dietary modifications significantly reduce gastrointestinal symptoms: Eat smaller portions distributed throughout the day Choose lean proteins and complex carbohydrates Avoid high-fat, spicy, or heavily seasoned foods Stop eating when feeling satisfied, not full Separate liquid consumption from meals by 30 minutes Timing strategies help minimize discomfort
Patients may experience mild to moderate gastrointestinal symptoms, including nausea, reduced appetite, and occasional loose stools
Glucagon receptor activation, for example, raises theoretical concerns about hepatic glucose output though clinical data from retatrutide trials show that the GLP-1 component effectively counterbalances this effect in the context of the triple agonist